0001209191-23-019599.txt : 20230317
0001209191-23-019599.hdr.sgml : 20230317
20230317160519
ACCESSION NUMBER: 0001209191-23-019599
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230315
FILED AS OF DATE: 20230317
DATE AS OF CHANGE: 20230317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Borgman Anne Elizabeth
CENTRAL INDEX KEY: 0001886388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 23742513
MAIL ADDRESS:
STREET 1: 9000 VIRGINIA MANOR ROAD
STREET 2: SUITE 200
CITY: BELTSVILLE
STATE: MD
ZIP: 20705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-15
0
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001886388
Borgman Anne Elizabeth
C/O SUTRO BIOPHARMA, INC.
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Stock Option (right to buy Common Stock)
5.40
2023-03-15
4
A
0
175000
0.00
A
2033-02-27
Common Stock
175000
175000
D
Restricted Stock Unit (RSU)
2023-03-15
4
A
0
150000
0.00
A
2027-02-28
Common Stock
150000
150000
D
The option vests as to 1/4th of the total shares on February 28, 2024 and then 1/48th of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on February 28, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
The RSUs vest as to 1/4th of the total shares annually beginning on February 28, 2024, subject to continued service through each vesting date.
/s/ Edward C. Albini as attorney-in-fact for Anne E. Borgman
2023-03-17